KRAS and familial pancreatic carcinoma: Notability, mutant KRAS enhanced the specific AA intake process named macropinocytosis in pancreatic cancer, resulting in maintaining the AA supply and thus promoting tumor progression (Liu et al., 2019; Qin et al., 2020).